AstraZeneca COVID-19 vaccine approved for use by health ministry (Louzir)

March 1, 2021

(TAP) - The Health Ministry granted Thursday a marketing authorisation to British AstraZeneca vaccine, said Chairman of the national COVID-19 vaccination campaign steering committee and director of Pasteur Institute Hechmi Louzir said.

'The possibility of having people with rare diseases join priority recipients will be considered shortly,' he added.

Louzir was speaking at a webinar on the theme: 'Living with a rare disease at the time of COVID-19.' The event was organised by the Tunisian Alliance for Rare Diseases on the International Rare Disease Day observed every year on the last day of February.

Nothing prevents people carrying rare diseases from getting vaccinated, Louzir highlighted, especially as any infection would put their lives at risk.

A specialised team will be sent to remote and isolated areas to ensure vaccination, Louzir further said.

He called, in this connection, for registering on the vaccination platform to determine intervention areas.

An authorisation for Johnson and Johnson vaccine is being looked at, he also said.

In Tunisia, around 600 people suffer from rare diseases. These diseases are often chronic and progressive.


93rd Vifor Pharma Group Annual Gene...
May 6, 2021
Smiths Medical and Ivenix Partner to Rev...
May 5, 2021
Study Investigates the Ability of Masimo...
May 3, 2021